Nephroprotective effect of apilarnil in lipopolysaccharide-induced sepsis through TLR4/NF-κB signaling pathway.


Journal

Life sciences
ISSN: 1879-0631
Titre abrégé: Life Sci
Pays: Netherlands
ID NLM: 0375521

Informations de publication

Date de publication:
01 Nov 2021
Historique:
received: 28 03 2021
revised: 26 07 2021
accepted: 05 08 2021
pubmed: 14 8 2021
medline: 8 10 2021
entrez: 13 8 2021
Statut: ppublish

Résumé

In this study, we aimed to investigate the protective effect of apilarnil on kidney damage in the sepsis model induced by LPS. 64 Sprague Dawley adult male rats were randomly divided into eight groups; control group, groups in which 0.2, 0.4 and 0.8 g/kg/bw apilarnil (API) was applied by oral gavage method for 10 days, LPS group in which 30 mg/kg/bw lipopolysaccharide (LPS) administered as intraperitoneally, groups in which LPS + 0.2, LPS+ 0.4 and LPS +0,8 API was applied. Six hour after the last administration the rats were anesthetized for euthanasia and kidney tissues were removed for RT-PCR analysis, immunohistochemical analysis and histopathologic analysis. According to the results of RT-PCR expression levels of IL-6, IL-1β, NF-κB, TNF-α and TLR4 were significantly reduced in the LPS + 0,8 API group. Immunoreactivity of TLR4, pNF-κB and TNF-α levels in the LPS + 0.8 apilarnil group were significantly lower than in the LPS and LPS + 0.2 apilarnil groups. Histologically, compared to the LPS group the glomerular damage score tended to decrease in the LPS + 0,4 API and LPS+ 0,8 API groups, while the tubulointerstitial injury score decreased especially in the LPS + 0,8 API group. In the present study, 0,8 g/kg dose of apilarnil promoted potential renoprotective effects which were achieved, at least in part, by the modulation of important markers of the local immune response in the model of LPS-induced sepsis.

Identifiants

pubmed: 34384831
pii: S0024-3205(21)00862-6
doi: 10.1016/j.lfs.2021.119875
pii:
doi:

Substances chimiques

Biological Products 0
Lipopolysaccharides 0
NF-kappa B 0
Protective Agents 0
Toll-Like Receptor 4 0
apilarnil 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

119875

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Nihal Inandiklioglu (N)

Department of Medical Biology, Faculty of Medicine, Yozgat Bozok University, Yozgat, Turkey. Electronic address: nihal.inandiklioglu@yobu.edu.tr.

Züleyha Doganyigit (Z)

Department of Histology and Embryology, Faculty of Medicine, Yozgat Bozok University, Yozgat, Turkey.

Aslı Okan (A)

Department of Histology and Embryology, Faculty of Medicine, Yozgat Bozok University, Yozgat, Turkey.

Emin Kaymak (E)

Department of Histology and Embryology, Faculty of Medicine, Yozgat Bozok University, Yozgat, Turkey.

Sibel Silici (S)

Department of Agricultural Biotechnology, Faculty of Agriculture, Erciyes University, Kayseri, Turkey.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH